What we do
We rethink breath. Deep Breath Intelligence is a healthtech company unleashing the huge potential of analyzing exhaled breath by applying machine learning algorithms.
We provide non-invasive solutions for early diagnosis of diseases and therapeutic drug monitoring – enabling better treatment by precision medicine. Our first product, DBI-EPIbreath®, is a test for drug monitoring in epilepsy which is CE-certified under IVDD.
We are working hard today on developing a broad range of products in different disease areas to take future precision medicine to the next level and improve people’s health.
News
DBI-EPIbreath®
50 mio people worldwide live with epilepsy, a sixth of them are children. Medical treatment helps in ~70% of cases and often requires therapeutic drug monitoring.
Therapeutic drug monitoring requires blood sampling and frequent visits to healthcare providers. Drug concentrations in blood often do not correlate with the treatment response and side effects and/or persistent seizures are common.
Our certified DBI-EPIbreath® test only needs an exhale to estimate the drug concentration of valproic acid in blood and estimates risks of severe side effects and seizures.
Drug monitoring and decision support
- In real-time
- Non-invasive
- Supports precision medicine